EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer

Francesco Segrado iD, Alessio Polymeropoulos, Michela Bianchi iD, Chiara Veronese, Roberto Agresti, Gianfranco Scaperrotta, Roberto Boffi, Rosalba Miceli, Rosaria Orlandi iD

Cancer Medicine · 2025-10 · 14 (19)

DOI: 10.1002/cam4.71279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 29.09.2025. Verfasst von Francesco Segrado und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Research and Metabolomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Nitric Oxide, Fractional Exhaled Nitric Oxide Testing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nitric oxide (NO), a gaseous messenger with pleiotropic functions, plays a role in cancer, including breast cancer (BC). Considering the high permeability and leakiness of NO across tissues and the increased levels of NO recently reported in exhaled breath and blood of patients with lung cancer, we explored exhaled NO levels in patients with BC in a future perspective of non‐invasive cancer detection. Patients and Methods Fractional exhaled NO (FeNO) levels were detected in the breath of 192 women with BC and malignancy‐free controls employing a widely used point‐of‐care (POC)‐based system previously developed for asthma monitoring.

Results

FeNO levels were lower in BC patients compared to controls, with the lowest levels in women with HER2‐expressing tumors. In univariate and multivariate analyses and after adjustment for age, smoking, and asthma, this difference was not significant. The effects of smoking were not statistically significant, whereas asthmatic subjects had significantly higher levels of FeNO ( p = 0.006). Neither menopause nor BMI had a significant impact on FeNO levels.

Conclusion

Our explorative work indicates that FeNO levels are heterogeneously detected in the breath of BC patients in the absence of confounding effects and are associated with the clinical characteristics of the disease. More sensitive detection of exhaled NO and larger cohorts enriched with ER negative BC are needed to further explore the potential of NO in non‐invasive detection of BC, either alone or in conjunction with other BC‐related volatile markers, and extending the NO measurement to blood or tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNitric OxideFractional Exhaled Nitric Oxide TestingHumansFemaleMiddle AgedAgedAdultBreath TestsExhalationCase-Control StudiesBiomarkers, Tumor

Stichwörter der Autor:innen

breast neoplasmsbreath testsearly detection of cancerfractional exhaled nitric oxide testingnitric oxide

Substanzen

Nitric OxideBiomarkers, Tumor

Autor:innen und Institutionen

  • Nutrition Research and Metabolomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Pulmonology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Integrated Breast Surgery, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Breast Imaging, Department of Diagnostic Imaging and Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

ORCID-Profile: Francesco Segrado, Michela Bianchi, Rosaria Orlandi

Förderung

  • Ministero della Salute

Zitieren

APA

Segrado, F., Polymeropoulos, A., Bianchi, M., Veronese, C., Agresti, R., Scaperrotta, G., Boffi, R., Miceli, R., & Orlandi, R. (2025). Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer. Cancer Medicine, 14(19). https://doi.org/10.1002/cam4.71279

Vancouver

Segrado F, Polymeropoulos A, Bianchi M, Veronese C, Agresti R, Scaperrotta G, et al. Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer. Cancer Medicine. 2025;14(19). doi:10.1002/cam4.71279

BibTeX
@article{Segrado2025,
  author = {Segrado, Francesco and Polymeropoulos, Alessio and Bianchi, Michela and Veronese, Chiara and Agresti, Roberto and Scaperrotta, Gianfranco and Boffi, Roberto and Miceli, Rosalba and Orlandi, Rosaria},
  title = {Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {19},
  doi = {10.1002/cam4.71279}
}
Kostenlos starten →